We identified a novel subset of macrophages that, through secretion of SPP1, bind to CD44 on tumour cells, activating the PDE3B pathway via the integrin enzyme pathway, thereby inducing chemotherapy resistance in TNBC patients. Here, CD44 is linked to neoplasm.